GANX Return on Tangible Equity | GAIN THERAPEUTICS, INC

GAIN THERAPEUTICS, INC (GANX) Return on Tangible Equity

2026-06-30: Return Tang Equity -178.06%.
2026-03-31: Return Tang Equity -151.64%.
2025-12-31: Return Tang Equity -108.60%.
2025-09-30: Return Tang Equity -328.15%.

Complete source-backed return tang equity history.

Available history: 2020-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-178.06%
2026-03-31	-151.64%
2025-12-31	-108.60%
2025-09-30	-328.15%
2025-06-30	-503.05%
2025-03-31	-362.08%
2024-12-31	-278.10%
2024-09-30	-239.83%
2024-06-30	-183.28%
2024-03-31	-244.67%
2023-12-31	-177.03%
2023-09-30	-303.08%
2023-06-30	-198.85%
2023-03-31	-128.51%
2022-12-31	-93.17%
2022-09-30	-71.20%
2022-06-30	-60.12%
2022-03-31	-46.23%
2021-12-31	-39.90%
2021-09-30	-32.83%
2021-06-30	-20.43%
2021-03-31	-12.24%
2020-12-31	-57.69%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-108.60%
2024-12-31	-278.10%
2023-12-31	-177.03%
2022-12-31	-93.17%
2021-12-31	-39.90%
2020-12-31	-57.69%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Lifevantage Corp (LFVN)	United States	$0.078B	15.40
Adicet Bio, Inc. (ACET)	United States	$0.078B	-0.81
Valion Bio, Inc. (VBIO)	United States	$0.077B
MAIA Biotechnology, Inc. (MAIA)	United States	$0.077B	-2.30
iBio, Inc. (IBIO)	United States	$0.077B	-2.94
Telomir Pharmaceuticals, Inc. (TELO)	United States	$0.084B
Lexaria Bioscience Corp. (LEXX)		$0.084B	-1.92
Verrica Pharmaceuticals Inc. (VRCA)	United States	$0.076B	-3.39
OS Therapies Inc (OSTX)	United States	$0.076B	-2.17
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)	United States	$0.086B